Dupixent® (dupilumab) smpc updated with long-term data reinforcing well-established safety profile in adults with moderate-to-severe atopic dermatitis

Dupixent ® (dupilumab) smpc update d with long-term data reinforc ing well -established safety profile in adults with moderate-to-severe atopic dermatitis

REGN Ratings Summary

REGN Quant Ranking